Reuter, S E, Evans, A M · Journal of internal medicine · 2011 · DOI
This study found that people with ME/CFS have lower levels of certain fat-like molecules called acylcarnitines in their blood compared to healthy people. These molecules are important for cells to produce energy from fat. The researchers suggest this difference might be related to how the body processes fatty acids, and they propose that taking omega-3 fatty acids along with carnitine supplements might help improve symptoms.
Mitochondrial dysfunction and energy metabolism abnormalities are proposed mechanisms in ME/CFS. This study provides biochemical evidence of altered fatty acid metabolism that could explain the severe fatigue characteristic of the condition, and it identifies potential biomarkers and therapeutic targets (carnitine and omega-3 supplementation) worth investigating further.
This study does not prove that carnitine deficiency causes ME/CFS—it only shows an association. The cross-sectional design cannot establish causation or distinguish whether the metabolic changes are a cause or consequence of illness. The proposed mechanism involving CPT-I activity is theoretical and was not directly measured; furthermore, whether supplementation would actually improve symptoms remains untested.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →